Theratase is a holding company. Through its subsidiaries, Co. is engaged in the development, manufacture, marketing and sale of enzymes and biochemicals to the medical diagnostic and pharmaceutical industries. Co.'s products include Alkaline Phosphatase, Glucose Oxidase, Peroxidase, Deoxyribonuclease and Hyaluronidase.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
A director at Ricardo sold 73,500 shares at 678p and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board members alo...
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...
The general evaluation of GOLD FIELDS LTD. (ZA), a company active in the Gold Mining industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date April 3, 2020, the closing price was ZAR 100.91 and its potential was estimated at ZAR 126.77.
The independent financial analyst theScreener just lowered the general evaluation of ZOETIS INCO. (US), active in the Pharmaceuticals industry. As regards its fundamental valuation, the title now shows 0 out of 4 stars while market behaviour can be considered defensive. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Neutral. As of the analysis date April 3, 2020, the closing price was USD 114.61 and its target price was estimated at USD 107.67.
The independent financial analyst theScreener just lowered the general evaluation of UNIVERSAL DISPLAY CORP. (US), active in the Semiconductors industry. As regards its fundamental valuation, the title still shows 1 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date April 3, 2020, the closing price was USD 118.31 and its target price was estimated at USD 112.39.
Unfortunately, this report is not available for the investor type or country you selected.Browse all ResearchPool reports
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.